Archive: CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response

97 views · Published 15 October 2015 · 15:02 · Indexed 20 October 2026

Channel: UW Video · 2015 · Education

Watch on YouTube

Dr. Alix Seif of The Children’s Hospital of Philadelphia speaks at the 4th International Conference on Immunotherapy in Pediatric Oncology (CIPO2015), hosted by Seattle Children’s Research Institute. 

Dr. Seif discusses the effectiveness of current single antigen-targeted immunotherapies for acute lymphoblastic leukemia (ALL) and how tolerance to tumor antigens preventing an immune response to neoantigen-bearing ALL can be partially overcome by the addition of an innate immune stimulant.

Alix Seif, MD, MPH, Assistant Professor, The Children’s Hospital of Philadelphia 

09/26/2015

http://www.seattlechildrens.org/research/

http://www.seattlechildrens.org/research/childhood-cancer/CIPO-2015/

https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel